CYCLERION THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable, Trade
CYCLERION THERAPEUTICS, INC. (CYCN) reported Increase (Decrease) in Accounts Payable, Trade of $1.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-04
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was $1.14M.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was -$51.00K, a 154.84% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $28.00K, a 67.44% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was $18.00K, a 12.50% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for fiscal 2023 was -$1.77M, a 255.17% decline from fiscal 2022.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for fiscal 2022 was $1.14M, a 68.19% increase from fiscal 2021.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for fiscal 2021 was $679.00K.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for fiscal 2020 was -$1.30M.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.14M derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-04 | $1.09M 10-Q · filed 2026-08-04 | $1.12M derived: sum of 3 quarters · filed 2026-08-04 | $1.14M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$51.00K S-4/A · filed 2026-07-22 | -$23.00K derived: sum of 2 quarters · filed 2026-07-22 | -$5.00K derived: sum of 3 quarters · filed 2026-07-22 | -$26.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $28.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | $46.00K derived: sum of 2 quarters · filed 2026-07-22 | $25.00K derived: sum of 3 quarters · filed 2026-08-04 | $118.00K S-4/A · filed 2026-07-22 |
| 2025-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$3.00K derived: sum of 2 quarters · filed 2026-08-04 | $90.00K 10-Q · filed 2025-11-12 | $176.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$21.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-04 | $72.00K 10-Q · filed 2026-08-04 | $158.00K derived: sum of 3 quarters · filed 2026-08-04 | $174.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $93.00K S-4/A · filed 2026-07-22 | $179.00K derived: sum of 2 quarters · filed 2026-07-22 | $195.00K derived: sum of 3 quarters · filed 2026-07-22 | $104.00K derived: sum of 4 quarters · filed 2026-07-22 |
| 2024-12-31 | $86.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | $102.00K derived: sum of 2 quarters · filed 2026-07-22 | $11.00K derived: sum of 3 quarters · filed 2026-07-22 | -$445.00K S-4/A · filed 2026-07-22 |
| 2024-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$75.00K derived: sum of 2 quarters · filed 2025-11-12 | -$531.00K 10-Q · filed 2025-11-12 | -$146.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$547.00K 10-Q · filed 2025-08-05 | -$162.00K derived: sum of 3 quarters · filed 2025-11-12 | -$1.21M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-03-31 | -$456.00K 10-Q · filed 2025-05-06 | -$71.00K derived: sum of 2 quarters · filed 2025-11-12 | -$1.12M derived: sum of 3 quarters · filed 2025-11-12 | -$3.18M derived: sum of 4 quarters · filed 2025-11-12 |
| 2023-12-31 | $385.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | -$666.00K derived: sum of 2 quarters · filed 2025-11-12 | -$2.73M derived: sum of 3 quarters · filed 2025-11-12 | -$1.77M 10-K/A · filed 2025-11-12 |
| 2023-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$3.11M derived: sum of 2 quarters · filed 2024-11-14 | -$2.16M 10-Q · filed 2024-11-14 | -$832.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$1.11M 10-Q · filed 2024-08-07 | $219.00K derived: sum of 3 quarters · filed 2024-08-07 | -$903.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $955.00K 10-Q · filed 2024-05-07 | $2.28M derived: sum of 2 quarters · filed 2024-05-07 | $1.16M derived: sum of 3 quarters · filed 2024-05-07 | $1.41M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $203.00K derived: sum of 2 quarters · filed 2024-03-05 | $451.00K derived: sum of 3 quarters · filed 2024-03-05 | $1.14M 10-K · filed 2024-03-05 |
| 2022-09-30 | -$1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$874.00K derived: sum of 2 quarters · filed 2023-11-13 | -$183.00K 10-Q · filed 2023-11-13 | $471.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $248.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $939.00K 10-Q · filed 2023-07-28 | $1.59M derived: sum of 3 quarters · filed 2023-07-28 | $1.38M derived: sum of 4 quarters · filed 2023-07-28 |
| 2022-03-31 | $691.00K 10-Q · filed 2023-05-12 | $1.34M derived: sum of 2 quarters · filed 2023-05-12 | $1.13M derived: sum of 3 quarters · filed 2023-05-12 | $1.42M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $442.00K derived: sum of 2 quarters · filed 2023-03-22 | $733.00K derived: sum of 3 quarters · filed 2023-03-22 | $679.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | -$212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $79.00K derived: sum of 2 quarters · filed 2022-11-03 | $25.00K 10-Q · filed 2022-11-03 | -$182.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $291.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $237.00K 10-Q · filed 2022-08-09 | $30.00K derived: sum of 3 quarters · filed 2022-08-09 | -$818.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$54.00K 10-Q · filed 2022-05-04 | -$261.00K derived: sum of 2 quarters · filed 2022-05-04 | -$1.11M derived: sum of 3 quarters · filed 2022-05-04 | -$329.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | -$207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$1.05M derived: sum of 2 quarters · filed 2022-02-24 | -$275.00K derived: sum of 3 quarters · filed 2022-02-24 | -$1.30M 10-K · filed 2022-02-24 |
| 2020-09-30 | -$848.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$68.00K derived: sum of 2 quarters · filed 2021-11-09 | -$1.09M 10-Q · filed 2021-11-09 | -$3.37M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $780.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$246.00K 10-Q · filed 2021-07-29 | -$2.52M derived: sum of 3 quarters · filed 2021-07-29 | -$4.14M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | -$1.03M 10-Q · filed 2021-04-30 | -$3.30M derived: sum of 2 quarters · filed 2021-04-30 | -$4.92M derived: sum of 3 quarters · filed 2021-04-30 | -$4.25M derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-12-31 | -$2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$3.90M derived: sum of 2 quarters · filed 2021-02-25 | -$3.22M derived: sum of 3 quarters · filed 2021-02-25 | -$331.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | -$1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$948.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.94M 10-Q · filed 2020-11-05 | $1.78M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $676.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $3.57M 10-Q · filed 2020-08-03 | $3.40M derived: sum of 3 quarters · filed 2020-08-03 | $3.21M derived: sum of 4 quarters · filed 2020-08-03 |
| 2019-03-31 | $2.89M 10-Q · filed 2020-05-04 | $2.73M derived: sum of 2 quarters · filed 2020-05-04 | $2.53M derived: sum of 3 quarters · filed 2020-05-04 | |
| 2018-12-31 | -$163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$359.00K derived: sum of 2 quarters · filed 2020-03-12 | $979.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | -$196.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.14M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $1.34M 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |